Today, HealthEx and 23andMe are launching a partnership that lets 23andMe members bring their medical records into 23andMe Health Summary alongside the genetic insights they already trust 23andMe to deliver. It's available now in beta.

I want to explain why this matters, and why we built HealthEx to make it possible.

The challenge when genomic and clinical data are separate and siloed

As a physician, I lost count of the patients who came in carrying real insight about themselves, sometimes a 23andMe report with a variant they wanted to discuss, sometimes a sharp question about a medication or family risk, and I couldn't meet them where they were. Not because their information wasn't useful, but because the rest of the health system hadn't caught up.

That gap, between what someone knows about their biology and what the rest of the health system can show them, is the gap this partnership closes.

Predisposition and reality

Genetics tells you what's possible. Your medical record shows you what's actually happening. Neither is complete on its own.

An LDL number means one thing for a person with no relevant genetic predisposition. It means something very different for someone who carries a variant that affects how they metabolize statins, or one that elevates their cardiovascular risk regardless of lifestyle. A blood pressure reading taken in isolation is data. The same reading, interpreted alongside a genetic profile, becomes a signal of where to focus.

This is what genetics has always promised and what clinical data alone cannot deliver. Brought together, the two layers start doing real work for the member. A clearer sense of which genetic risks are theoretical and which are showing up in their numbers today. Better questions to bring into their next appointment. A more informed view of the screenings, lifestyle changes, or conversations they may want to prioritize.

Why this is the right moment

23andMe has spent nearly two decades giving members access to their own biology, and they have never stopped pushing the question of what comes next. Millions of members want more than a static report. They want the bloodwork that confirms or complicates what their DNA suggested, the medical history that shows how their body has actually responded over time, the clinical context that turns insight into action.

23andMe Health Summary is built to bring all of that together. It uses AI to connect genetics, medical records, labs, and lifestyle data into a single view, surfacing the areas each member should prioritize and the next steps they can take. By bringing HealthEx into Health Summary, members can now connect their medical records directly, on their terms, in minutes.

"For nearly two decades, 23andMe has been working toward a future where genetic information helps people get ahead of their health," said Anne Wojcicki, Co-founder and CEO of 23andMe. "Bringing medical records into the picture is the next step. With HealthEx, our members can more fully connect their genetics and their clinical history, and use AI to make sense of both."

I've spent time with Anne and the 23andMe team over the past year, and have seen how passionate Anne is about making genomic data more available and actionable. What strikes me is how clearly they see the future they've been building toward - one in which a person's genetic profile actively guides their health journey, and care moves toward prevention. Delivering that future takes a platform purpose-built for the moment, which is exactly why we built HealthEx.

Control is the foundation

The moment that decides whether a health product earns trust is the first time a member wants to disconnect.

If that's friction-filled or unclear, the product has failed - no matter what the privacy policy says. If it's simple and immediate, the member learns something important: that they were always in control, and the company meant it.

We built HealthEx that way. Connecting records is fast. Disconnecting is faster. Members can review every connection they've made, change what's shared, or delete the data entirely from a single place. The identity verification, encryption, and federal standards we operate under as a TEFCA Individual Access Services provider are real and necessary - but the part members feel is the ability to revoke permissions, at any time, without explanation.

That's what makes the rest of the partnership possible. A member who can disconnect with a single tap is a member who can connect with confidence.

What comes next

The first twenty years of consumer genomics were about access - getting the data into people's hands, making it understandable, building the trust that millions of members now extend to 23andMe.

The next chapter looks different. The data moves with the person, into the products, conversations, and appointments where it can actually be useful to them. Insights draw on the full picture - genetic and clinical, baseline and current, predisposition and reality. The work of integrating it all stops falling on the individual.

The members joining the Beta will be the first to experience this, and the ones who shape what comes next - the same way 23andMe members have shaped every chapter that came before.

We're proud to be building this with them.